---
layout: minimal-medicine
title: Capecitabine + Cyclophosphamide
---

# Capecitabine + Cyclophosphamide
### Generic Name
Capecitabine + Cyclophosphamide (Combination Therapy)


### Usage

Capecitabine and cyclophosphamide are not typically used as single agents but are often administered together as a combination chemotherapy regimen. This combination is primarily used in the treatment of various types of cancer, most notably:

* **Breast cancer:**  This combination is frequently employed in the treatment of metastatic breast cancer (cancer that has spread to other parts of the body) and sometimes in the adjuvant setting (after surgery to reduce the risk of recurrence).  The specific use depends on the type and stage of the breast cancer, as well as other patient factors.

* **Other solid tumors:**  While less common than in breast cancer, this combination may be considered for other types of advanced solid tumors depending on the specific cancer type and the oncologist's assessment.

It's crucial to understand that this is not a first-line treatment for all cancers and its use is highly dependent on individual patient characteristics and the specific cancer being treated.  The decision to use capecitabine and cyclophosphamide is made by an oncologist based on a comprehensive evaluation.


### Dosage

Dosage of capecitabine and cyclophosphamide in combination chemotherapy is highly individualized and determined by the treating oncologist. It's based on factors such as the patient's overall health, the type and stage of cancer, and previous treatments.  There is no standard "one size fits all" dosage.  The regimen often involves cycles of treatment, with periods of medication followed by rest periods.

**Dosage examples are given for illustrative purposes only and should never be interpreted as a prescription.  Always follow your oncologist's specific instructions.**

* **Capecitabine:** This is usually administered orally (in tablet form). The dose can vary significantly, typically in the range of 600-1250 mg/m² twice daily for a specified duration within each treatment cycle.

* **Cyclophosphamide:** This can be given intravenously (IV) or orally, although IV administration is more common in combination regimens.  Doses typically range from 600-1000 mg/m² given intravenously over a short period during each cycle.

* **Pediatric use:** The use of this combination in pediatric patients is highly specialized and only used under strict medical supervision. Pediatric oncology specialists determine the dosage based on age, weight, and the specific type of cancer.


### Side Effects

The combination of capecitabine and cyclophosphamide can cause a wide range of side effects, varying in severity from mild to life-threatening.  It's important to report any unusual symptoms to your doctor immediately.

**Common Side Effects:**

* Nausea and vomiting
* Diarrhea
* Fatigue
* Hair loss (alopecia)
* Mouth sores (stomatitis)
* Skin rash
* Hand-foot syndrome (palmar-plantar erythrodysesthesia)
* Decreased white blood cell count (neutropenia), increasing risk of infection
* Decreased platelet count (thrombocytopenia), increasing risk of bleeding


**Serious, but Less Common Side Effects:**

* Severe infections due to neutropenia
* Severe bleeding due to thrombocytopenia
* Kidney damage
* Heart problems
* Nerve damage (peripheral neuropathy)
* Secondary cancers (long-term risk)

**Note:** This is not an exhaustive list.  Your oncologist can provide a more detailed list of potential side effects based on your individual circumstances.


### How it Works

Capecitabine is a prodrug; it is converted into an active form within the body's tumor cells that inhibits an enzyme crucial for cell division (thymidylate synthase). This prevents the tumor cells from replicating their DNA, leading to their death.

Cyclophosphamide is an alkylating agent.  It damages the DNA of cancer cells, preventing their replication and causing cell death.  The combination of capecitabine and cyclophosphamide targets cancer cells through different mechanisms, potentially increasing their effectiveness and reducing the chance of drug resistance.


### Precautions

* **Contraindications:** This combination should not be used in patients with severe bone marrow suppression, severe liver or kidney disease, or those with certain hypersensitivities to the drugs.  Pregnancy and breastfeeding are also absolute contraindications.

* **Drug Interactions:** Many drugs can interact with capecitabine and cyclophosphamide. It's essential to inform your oncologist of all medications, including over-the-counter drugs and herbal supplements, that you are taking.

* **Specific Warnings:**  Older adults, patients with pre-existing medical conditions, and those with impaired organ function may require close monitoring and dose adjustments.  The risk of serious side effects is higher in these groups.

* **Pregnancy and Breastfeeding:**  This combination is contraindicated during pregnancy and breastfeeding. Effective contraception is essential.


### FAQs

* **Q: How long will I be on this treatment?**  A: The duration of treatment varies greatly depending on individual responses and cancer type. Your oncologist will determine the appropriate treatment duration.

* **Q: What should I do if I experience side effects?** A: Report any side effects, even mild ones, to your oncologist immediately. They can provide appropriate management strategies.

* **Q: How is this medication stored?** A: Follow the instructions provided with your medication.  Capecitabine tablets are usually stored at room temperature, protected from moisture.  Cyclophosphamide (IV) is handled and stored according to hospital protocols.

* **Q: Can I drink alcohol while taking this treatment?** A:  It's best to avoid alcohol while undergoing this therapy, as it can exacerbate some side effects, particularly nausea and gastrointestinal distress.  Discuss this with your oncologist.

* **Q:  Are there alternatives to this combination therapy?** A: Yes, there are many other chemotherapy regimens available. The choice of treatment depends on several factors, and your oncologist will help you find the best approach for your specific situation.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider or oncologist for any health concerns or before making any decisions related to your health or treatment.  The information provided here is not exhaustive and individual treatment plans should be developed and managed by qualified medical professionals.
